Cellectis (CLLS) Cash & Current Investments (2016 - 2023)
Historic Cash & Current Investments for Cellectis (CLLS) over the last 11 years, with Q3 2023 value amounting to $67.4 million.
- Cellectis' Cash & Current Investments fell 4340.0% to $67.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $67.4 million, marking a year-over-year decrease of 4340.0%. This contributed to the annual value of $104.4 million for FY2022, which is N/A changed from last year.
- Latest data reveals that Cellectis reported Cash & Current Investments of $67.4 million as of Q3 2023, which was down 4340.0% from $94.3 million recorded in Q2 2023.
- Over the past 5 years, Cellectis' Cash & Current Investments peaked at $471.9 million during Q3 2019, and registered a low of $20.1 million during Q1 2022.
- For the 5-year period, Cellectis' Cash & Current Investments averaged around $233.5 million, with its median value being $227.8 million (2021).
- As far as peak fluctuations go, Cellectis' Cash & Current Investments tumbled by 9394.47% in 2021, and later skyrocketed by 38758.98% in 2023.
- Quarter analysis of 5 years shows Cellectis' Cash & Current Investments stood at $360.9 million in 2019, then dropped by 25.68% to $268.2 million in 2020, then dropped by 21.3% to $211.1 million in 2021, then plummeted by 50.54% to $104.4 million in 2022, then plummeted by 35.49% to $67.4 million in 2023.
- Its Cash & Current Investments was $67.4 million in Q3 2023, compared to $94.3 million in Q2 2023 and $97.9 million in Q1 2023.